OCUMENSION-B (01477) Grants Stock Options and Awards

Stock News

Yesterday

OCUMENSION-B (01477) announced that the Board of Directors considers it necessary to implement incentive measures to support the Group's strategic growth objectives and maintain a competitive advantage in talent recruitment and retention. To recognize the long-term dedication and valuable contributions of the grantees towards achieving the Group's research and development (R&D) and commercial milestones, the Board resolved on May 12, 2026, to grant 7,932,100 stock options, covering 7,932,100 shares, to 498 grantees (including Dr. Hu Zhaopeng, an executive director of the Company, and one senior management member) under the 2021 Share Option Scheme. Concurrently, 7,932,100 share awards, covering 7,932,100 shares, were granted to the same 498 grantees (including Dr. Hu and one senior management member) under the 2021 Share Award Scheme. These grants represent approximately 0.97% and 0.97%, respectively, of the Company's total issued and outstanding share capital (excluding treasury shares) as of the grant date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1146748953"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146748953\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146748953?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 21:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146748953","market":"sg","top_or_hot":-1,"title":"OCUMENSION-B (01477) Grants Stock Options and Awards","media":"Stock News","content":"<p>OCUMENSION-B (01477) announced that the Board of Directors considers it necessary to implement incentive measures to support the Group's strategic growth objectives and maintain a competitive advantage in talent recruitment and retention. To recognize the long-term dedication and valuable contributions of the grantees towards achieving the Group's research and development (R&D) and commercial milestones, the Board resolved on May 12, 2026, to grant 7,932,100 stock options, covering 7,932,100 shares, to 498 grantees (including Dr. Hu Zhaopeng, an executive director of the Company, and one senior management member) under the 2021 Share Option Scheme. Concurrently, 7,932,100 share awards, covering 7,932,100 shares, were granted to the same 498 grantees (including Dr. Hu and one senior management member) under the 2021 Share Award Scheme. These grants represent approximately 0.97% and 0.97%, respectively, of the Company's total issued and outstanding share capital (excluding treasury shares) as of the grant date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCUMENSION-B (01477) Grants Stock Options and Awards</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCUMENSION-B (01477) Grants Stock Options and Awards\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-12 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OCUMENSION-B (01477) announced that the Board of Directors considers it necessary to implement incentive measures to support the Group's strategic growth objectives and maintain a competitive advantage in talent recruitment and retention. To recognize the long-term dedication and valuable contributions of the grantees towards achieving the Group's research and development (R&D) and commercial milestones, the Board resolved on May 12, 2026, to grant 7,932,100 stock options, covering 7,932,100 shares, to 498 grantees (including Dr. Hu Zhaopeng, an executive director of the Company, and one senior management member) under the 2021 Share Option Scheme. Concurrently, 7,932,100 share awards, covering 7,932,100 shares, were granted to the same 498 grantees (including Dr. Hu and one senior management member) under the 2021 Share Award Scheme. These grants represent approximately 0.97% and 0.97%, respectively, of the Company's total issued and outstanding share capital (excluding treasury shares) as of the grant date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1146748953","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146748953","pubTimestamp":1778592620,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"OCUMENSION-B (01477) announced that the Board of Directors considers it necessary to implement incentive measures to support the Group's strategic growth objectives and maintain a competitive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","01477":"欧康维视生物-B","BK1574":"生物医药B类股"},"translate_title":"欧康维-B(01477)授出购股权及奖励","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01477":1},"content_text":"OCUMENSION-B (01477) announced that the Board of Directors considers it necessary to implement incentive measures to support the Group's strategic growth objectives and maintain a competitive advantage in talent recruitment and retention. To recognize the long-term dedication and valuable contributions of the grantees towards achieving the Group's research and development (R&D) and commercial milestones, the Board resolved on May 12, 2026, to grant 7,932,100 stock options, covering 7,932,100 shares, to 498 grantees (including Dr. Hu Zhaopeng, an executive director of the Company, and one senior management member) under the 2021 Share Option Scheme. Concurrently, 7,932,100 share awards, covering 7,932,100 shares, were granted to the same 498 grantees (including Dr. Hu and one senior management member) under the 2021 Share Award Scheme. These grants represent approximately 0.97% and 0.97%, respectively, of the Company's total issued and outstanding share capital (excluding treasury shares) as of the grant date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}